Clinical Trial Update: Study to Evaluate Daptomycin Given During Dialysis and After Dialysis [Phase 1]

View source ↗

Summary

Phase 1 trial assessing daptomycin administration during and after dialysis in patients with end-stage renal disease; study completed with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Renal Failure Chronic Requiring Hemodialysis

Drugs mentioned

• Daptomycin (daptomycin)

Snippet

Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: End-stage Renal Disease, Renal Failure Chronic Requiring Hemodialysis | Phase 1 | Status: COMPLETED | Results posted: 2011-10-25